Dafna Capital Management LLC Applied Genetic Technologies Corp Transaction History

Dafna Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.62 - $5.23 $1.56 Million - $2.25 Million	-430,111 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$3.94 - $8.19 $1.86 Million - $3.88 Million	-473,318 Reduced 52.39%	430,111 $2.18 Million
Q4 2020 Feb 16, 2021	SELL	$3.99 - $5.7 $764,922 - $1.09 Million	-191,710 Reduced 17.51%	903,429 $3.7 Million
Q3 2020 Nov 16, 2020	SELL	$4.38 - $6.43 $287,936 - $422,701	-65,739 Reduced 5.66%	1,095,139 $5.32 Million
Q1 2020 May 15, 2020	BUY	$2.36 - $9.86 $1.89 Million - $7.9 Million	801,688 Added 223.19%	1,160,878 $3.81 Million
Q4 2018 Feb 14, 2019	SELL	$2.28 - $7.15 $1,527 - $4,790	-670 Reduced 0.19%	359,190 $894,000
Q3 2018 Nov 14, 2018	SELL	$3.85 - $7.35 $235,389 - $449,379	-61,140 Reduced 14.52%	359,860 $2.63 Million
Q3 2017 Nov 14, 2017	BUY	$3.55 - $5.25 $1.49 Million - $2.21 Million	421,000	421,000 $1.66 Million

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Dafna Capital Management LLC with notifications on news.